The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Evidence for Selective Advantage of Pathogenic FGFR2 Mutations in the Male Germ Line
Abstract
Observed mutation rates in humans appear higher in male than female gametes and often increase with paternal age. This bias, usually attributed to the accumulation of replication errors or inefficient repair processes, has been difficult to study directly. Here, we describe a sensitive method to quantify substitutions at nucleotide 755 of the fibroblast growth factor receptor 2 ( FGFR2 ) gene in sperm. Although substitution levels increase with age, we show that even high levels originate from infrequent mutational events. We propose that these FGFR2 mutations, although harmful to embryonic development, are paradoxically enriched because they confer a selective advantage to the spermatogonial cells in which they arise.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of Cell Fate Decision of Undifferentiated Spermatogonia by GDNF
Meng, X., Lindahl, M., Hyvönen, M. E., Parvinen, M., de Rooij, D. G., Hess, M. W., Raatikainen-Ahokas, A., Sainio, K., Rauvala, H., Lakso, M., et al. (2000) · Science · doi:10.1126/science.287.5457.1489 · Cited by 1,404
Estimate of the Mutation Rate per Nucleotide in Humans
Nachman, M. W., & Crowell, S. L. (2000) · Genetics · doi:10.1093/genetics/156.1.297 · Cited by 1,209
Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome
Wilkie, A. O. M., Slaney, S. F., Oldridge, M., Poole, M. D., Ashworth, G. J., Hockley, A. D., Hayward, R. D., David, D. J., Pulleyn, L. J., Rutland, P., et al. (1995) · Nature Genetics · doi:10.1038/ng0295-165 · Cited by 935
Self-citationThe origins, patterns and implications of human spontaneous mutation
Crow, J. F. (2000) · Nature Reviews Genetics · doi:10.1038/35049558 · Cited by 928
Nomenclature for the description of human sequence variations
den Dunnen, J., & Antonarakis, S. (2001) · Human Genetics · doi:10.1007/s004390100505 · Cited by 896
Tomlinson, I. P. M., Novelli, M. R., & Bodmer, W. F. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14800 · Cited by 458
Direct estimates of human per nucleotide mutation rates at 20 loci causing mendelian diseases
Kondrashov, A. S. (2003) · Human Mutation · doi:10.1002/humu.10147 · Cited by 336
Exclusive paternal origin of new mutations in Apert syndrome
Moloney, D. M., Slaney, S. R., Oldridge, M., Wall, S. A., Sahlin, P., Stenman, G., & Wilkie, A. O. M. (1996) · Nature Genetics · doi:10.1038/ng0596-48 · Cited by 320
Self-citationJang, J., Shin, K., & Park, J.-G. (2001) · PubMed · Cited by 273
Kan, S.-H., Elanko, N., Johnson, D., Cornejo-Roldan, L., Cook, J., Reich, E. W., Tomkins, S., Verloes, A., Twigg, S. R. F., Rannan-Eliya, S., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338758 · Cited by 265
Self-citation
Cited by
Structural basis for fibroblast growth factor receptor activation
Mohammadi, M., Olsen, S. K., & Ibrahimi, O. A. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.008 · Cited by 735
Oxidative stress and male reproductive health
Aitken, R., Smith, T., Jobling, M., Baker, M., & De Iuliis, G. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122203 · Cited by 598
Horton, W. A., Hall, J. G., & Hecht, J. T. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61090-3 · Cited by 582
New insights into the generation and role of de novo mutations in health and disease
Acuna-Hidalgo, R., Veltman, J. A., & Hoischen, A. (2016) · Genome Biology · doi:10.1186/s13059-016-1110-1 · Cited by 453
Genomic rearrangements and sporadic disease
Lupski, J. R. (2007) · Nature Genetics · doi:10.1038/ng2084 · Cited by 424
Metadata
- Authors
- Goriely, A., McVean, G. A. T., Röjmyr, M., Ingemarsson, B., & Wilkie, A. O. M.
- Venue
- Science
- Published
- 2003-08
- Volume
- 301
- Issue
- 5633
- Pages
- 643-646
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2073966710
- Cited by
- 310
- References
- 23
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evidence for Selective Advantage of Pathogenic FGFR2 Mutations in the Male Germ Line. https://app.cochat.ai/papers/10.1126/science.1085710
- The paper
- Goriely, A., McVean, G. A. T., Röjmyr, M., Ingemarsson, B., & Wilkie, A. O. M. (2003). Evidence for Selective Advantage of Pathogenic FGFR2 Mutations in the Male Germ Line. Science. https://doi.org/10.1126/science.1085710
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.